Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults
- PMID: 34599655
- PMCID: PMC8563635
- DOI: 10.1007/s00125-021-05571-8
Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults
Abstract
Aims/hypothesis: Data on type 1 diabetes incidence and prevalence are limited, particularly for adults. This study aims to estimate global numbers of incident and prevalent cases of type 1 diabetes in 2017 for all age groups, by country and areas defined by income and region.
Methods: Incidence rates of type 1 diabetes in children (available from 94 countries) from the IDF Atlas were used and extrapolated to countries without data. Age-specific incidence rates in adults (only known across full age range for fewer than ten countries) were obtained by applying scaling ratios for each adult age group relative to the incidence rate in children. Age-specific incidence rates were applied to population estimates to obtain incident case numbers. Duration of diabetes was estimated from available data and adjusted using differences in childhood mortality rate between countries from United Nations demographic data. Prevalent case numbers were derived by modelling the relationship between prevalence, incidence and disease duration. Sensitivity analyses were performed to quantify the impact of alternative assumptions and model inputs.
Results: Global numbers of incident and prevalent cases of type 1 diabetes were estimated to be 234,710 and 9,004,610, respectively, in 2017. High-income countries, with 17% of the global population, accounted for 49% of global incident cases and 52% of prevalent cases. Asia, which has the largest proportion of the world's population (60%), had the largest number of incident (32%) and prevalent (31%) cases of type 1 diabetes. Globally, 6%, 35%, 43% and 16% of prevalent cases were in the age groups 0-14, 15-39, 40-64 and 65+ years, respectively. Based on sensitivity analyses, the estimates could deviate by ±15%.
Conclusions/interpretation: Globally, type 1 diabetes represents about 2% of the estimated total cases of diabetes, ranging from less than 1% in certain Pacific countries to more than 15% in Northern European populations in 2017. This study provides information for the development of healthcare and policy approaches to manage type 1 diabetes. The estimates need further validation due to limitations and assumptions related to data availability and estimation methods.
Keywords: Adults; Children; Epidemiology; Global estimates; Incidence; Prevalence; Type 1 diabetes.
© 2021. The Author(s).
Figures



Similar articles
-
Diabetes in the young - a global view and worldwide estimates of numbers of children with type 1 diabetes.Diabetes Res Clin Pract. 2014 Feb;103(2):161-75. doi: 10.1016/j.diabres.2013.11.005. Epub 2013 Dec 1. Diabetes Res Clin Pract. 2014. PMID: 24331235
-
Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.Diabetes Res Clin Pract. 2019 Nov;157:107842. doi: 10.1016/j.diabres.2019.107842. Epub 2019 Sep 10. Diabetes Res Clin Pract. 2019. PMID: 31518658
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study.Lancet Diabetes Endocrinol. 2022 Oct;10(10):741-760. doi: 10.1016/S2213-8587(22)00218-2. Epub 2022 Sep 13. Lancet Diabetes Endocrinol. 2022. PMID: 36113507
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7. Lancet. 2015. PMID: 26063472 Free PMC article. Review.
Cited by
-
Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019.Diabetes Metab J. 2023 Mar;47(2):211-219. doi: 10.4093/dmj.2022.0346. Epub 2023 Feb 7. Diabetes Metab J. 2023. PMID: 36746784 Free PMC article.
-
Health Technology Assessment: Evaluation of 7 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus.Risk Manag Healthc Policy. 2024 Apr 23;17:1053-1067. doi: 10.2147/RMHP.S455897. eCollection 2024. Risk Manag Healthc Policy. 2024. PMID: 38680477 Free PMC article. Review.
-
Association of Polycyclic Aromatic Hydrocarbons Urine Metabolites with Type 1 Diabetes.J Diabetes Res. 2023 Jun 23;2023:6692810. doi: 10.1155/2023/6692810. eCollection 2023. J Diabetes Res. 2023. PMID: 37396492 Free PMC article.
-
Health system responses for type 1 diabetes: A scoping review.Diabet Med. 2022 Jul;39(7):e14805. doi: 10.1111/dme.14805. Epub 2022 Feb 24. Diabet Med. 2022. PMID: 35124856 Free PMC article.
-
Single-cell RNA sequencing analysis reveals the relationship of bone marrow and osteopenia in STZ-induced type 1 diabetic mice.J Adv Res. 2022 Nov;41:145-158. doi: 10.1016/j.jare.2022.01.006. Epub 2022 Jan 21. J Adv Res. 2022. PMID: 36328744 Free PMC article.
References
-
- World Health Organization . Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: World Health Organization; 2013.
-
- World Health Oragnization . Global report on diabetes. Geneva: World Heath Organization; 2016.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical